173 related articles for article (PubMed ID: 30081658)
1. Sodium Nitrite-Mediated Cardioprotection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Cost-Effectiveness Analysis.
Jones DA; Whittaker P; Rathod KS; Richards AJ; Andiapen M; Antoniou S; Mathur A; Ahluwalia A
J Cardiovasc Pharmacol Ther; 2019 Mar; 24(2):113-119. PubMed ID: 30081658
[TBL] [Abstract][Full Text] [Related]
2. Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention.
Barton GR; Irvine L; Flather M; McCann GP; Curzen N; Gershlick AH;
Value Health; 2017 Jun; 20(6):745-751. PubMed ID: 28577691
[TBL] [Abstract][Full Text] [Related]
3. Associations Between Hospital Length of Stay, 30-Day Readmission, and Costs in ST-Segment-Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention: A Nationwide Readmissions Database Analysis.
Jang SJ; Yeo I; Feldman DN; Cheung JW; Minutello RM; Singh HS; Bergman G; Wong SC; Kim LK
J Am Heart Assoc; 2020 Jun; 9(11):e015503. PubMed ID: 32468933
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
[TBL] [Abstract][Full Text] [Related]
5. Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction).
Niccoli G; Rigattieri S; De Vita MR; Valgimigli M; Corvo P; Fabbiocchi F; Romagnoli E; De Caterina AR; La Torre G; Lo Schiavo P; Tarantino F; Ferrari R; Tomai F; Olivares P; Cosentino N; D'Amario D; Leone AM; Porto I; Burzotta F; Trani C; Crea F
JACC Cardiovasc Interv; 2013 Jun; 6(6):580-9. PubMed ID: 23683738
[TBL] [Abstract][Full Text] [Related]
6. Combined Intrahospital Remote Ischemic Perconditioning and Postconditioning Improves Clinical Outcome in ST-Elevation Myocardial Infarction.
Stiermaier T; Jensen JO; Rommel KP; de Waha-Thiele S; Fuernau G; Desch S; Thiele H; Eitel I
Circ Res; 2019 May; 124(10):1482-1491. PubMed ID: 30929570
[TBL] [Abstract][Full Text] [Related]
7. Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI).
Siddiqi N; Neil C; Bruce M; MacLennan G; Cotton S; Papadopoulou S; Feelisch M; Bunce N; Lim PO; Hildick-Smith D; Horowitz J; Madhani M; Boon N; Dawson D; Kaski JC; Frenneaux M;
Eur Heart J; 2014 May; 35(19):1255-62. PubMed ID: 24639423
[TBL] [Abstract][Full Text] [Related]
8. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
[TBL] [Abstract][Full Text] [Related]
9. Potential economic consequences of a cardioprotective agent for patients with myocardial infarction: modelling study.
Verhoef TI; Morris S; Mathur A; Singer M
BMJ Open; 2015 Nov; 5(11):e008164. PubMed ID: 26567251
[TBL] [Abstract][Full Text] [Related]
10. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
Perera D; Crake T; Lee V
Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
[TBL] [Abstract][Full Text] [Related]
11. Systematic investment in the delivery of guideline-coherent therapy reduces mortality and overall costs in patients with ST-elevation myocardial infarction: Results from the Stent for Life economic model for Romania, Portugal, Basque Country and Kemerovo region.
Wein B; Bashkireva A; Au-Yeung A; Yoculan A; Vinereanu D; Deleanu D; Pereira H; Pereira E; de Mello S; Rumoroso JR; Ganyukov V; Wijns W; Naber CK
Eur Heart J Acute Cardiovasc Care; 2020 Dec; 9(8):902-910. PubMed ID: 31557050
[TBL] [Abstract][Full Text] [Related]
12. Acute and 1-Year Hospitalization Costs for Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention: Results From the TRANSLATE-ACS Registry.
Cowper PA; Knight JD; Davidson-Ray L; Peterson ED; Wang TY; Mark DB;
J Am Heart Assoc; 2019 Apr; 8(8):e011322. PubMed ID: 30975005
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness of Percutaneous Coronary Intervention Compared With Medical Therapy for Ischemic Heart Disease in Japan.
Kodera S; Morita H; Kiyosue A; Ando J; Komuro I
Circ J; 2019 Jun; 83(7):1498-1505. PubMed ID: 31168046
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
Coleman CI; McKay RG; Boden WE; Mather JF; White CM
Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
[TBL] [Abstract][Full Text] [Related]
15. Costs of transradial percutaneous coronary intervention.
Amin AP; House JA; Safley DM; Chhatriwalla AK; Giersiefen H; Bremer A; Hamon M; Baklanov DV; Aluko A; Wohns D; Mathias DW; Applegate RA; Cohen DJ; Marso SP
JACC Cardiovasc Interv; 2013 Aug; 6(8):827-34. PubMed ID: 23871512
[TBL] [Abstract][Full Text] [Related]
16. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
17. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights.
Haig C; Carrick D; Carberry J; Mangion K; Maznyczka A; Wetherall K; McEntegart M; Petrie MC; Eteiba H; Lindsay M; Hood S; Watkins S; Davie A; Mahrous A; Mordi I; Ahmed N; Teng Yue May V; Ford I; Radjenovic A; Welsh P; Sattar N; Oldroyd KG; Berry C
JACC Cardiovasc Imaging; 2019 Jun; 12(6):993-1003. PubMed ID: 30031700
[TBL] [Abstract][Full Text] [Related]
18. Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI).
Siddiqi N; Bruce M; Neil CJ; Jagpal B; Maclennon G; Cotton SC; Papadopoulo SA; Bunce N; Lim P; Schwarz K; Singh S; Hildick-Smith D; Horowitz JD; Madhani M; Boon N; Kaski JC; Dawson D; Frenneaux MP
J Transl Med; 2013 May; 11():116. PubMed ID: 23648219
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study.
Wu Y; Fu X; Feng Q; Gu X; Hao G; Fan W; Jiang Y
BMC Cardiovasc Disord; 2020 Jun; 20(1):308. PubMed ID: 32590944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
